Mr. Icahn sent an open letter to shareholders calling on them to vote against Cigna’s proposed takeover of the pharmacy benefits manager. He dubbed the deal a “$60 billion folly” with too high a price tag.
Mr. Icahn also argued Express Scripts faces regulatory headwinds as PBMs’ rebate system is increasingly scrutinized. He said opposition to the “highly flawed rebate system will likely lower Express Scripts’ profitability dramatically.”
“Even if they do survive, exposing Cigna, a thriving company, to these risks by acquiring Express Scripts now is inexplicably ridiculous,” Mr. Icahn said. “Purchasing Express Scripts may well become one of the worst blunders in corporate history.”
News of Mr. Icahn’s opposition to the deal surfaced Aug. 2. On the same day, Cigna CEO David Cordani told analysts during an earnings call that the deal is in the interest of shareholders. He said the deal will reward drugmakers for outcomes instead of consumption, according to Forbes.
More articles on payers:
BCBS of Texas to stop reimbursing nonemergent ER visits
Ex-Blue Cross Rhode Island CEO received $1.15M payout 1 year after departure
U of Colorado Hospital, School of Medicine providers no longer accepting UnitedHealthcare MA patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
